Aigen Investment Management LP acquired a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,312 shares of the real estate investment trust's stock, valued at approximately $318,000.
Several other large investors have also recently bought and sold shares of NHI. Entropy Technologies LP purchased a new position in shares of National Health Investors in the 1st quarter worth about $310,000. Invesco Ltd. raised its holdings in shares of National Health Investors by 1.6% during the first quarter. Invesco Ltd. now owns 127,008 shares of the real estate investment trust's stock valued at $9,381,000 after acquiring an additional 1,983 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of National Health Investors by 4.4% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 31,114 shares of the real estate investment trust's stock valued at $2,298,000 after buying an additional 1,319 shares during the period. Centersquare Investment Management LLC raised its position in shares of National Health Investors by 25.7% in the 1st quarter. Centersquare Investment Management LLC now owns 495,971 shares of the real estate investment trust's stock worth $36,632,000 after acquiring an additional 101,538 shares in the last quarter. Finally, New Age Alpha Advisors LLC purchased a new position in National Health Investors during the first quarter valued at $1,868,000. 62.51% of the stock is owned by institutional investors.
National Health Investors Stock Up 0.6%
Shares of NHI stock traded up $0.45 during trading hours on Monday, reaching $75.11. 53,772 shares of the company's stock were exchanged, compared to its average volume of 248,364. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $86.13. The stock's 50 day moving average is $71.55 and its 200-day moving average is $72.29. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. The company has a market cap of $3.57 billion, a price-to-earnings ratio of 24.00, a P/E/G ratio of 3.75 and a beta of 0.73.
National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.06. The business had revenue of $70.27 million during the quarter, compared to the consensus estimate of $86.46 million. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%. The company's quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the company earned $1.18 earnings per share. Analysts predict that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a $0.92 dividend. This is an increase from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date is Tuesday, September 30th. National Health Investors's payout ratio is currently 115.02%.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on NHI. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a report on Thursday, July 10th. Truist Financial boosted their price target on National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a report on Friday. Finally, Wedbush upgraded National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. Two equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $85.40.
Check Out Our Latest Analysis on NHI
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Articles

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.